Delighted to announce news of recent patent grants for OmniSpirant Therapeutics' disruptive regenerative gene therapy platform technology - 'OmniSomes'. This includes a US grant last month, adding to our grants in Japan, Russia and Eurasia. We are already moving onwards to more patent filings to build out our IP portfolio, especially for our innovative platform-based pan-cancer gene therapy (OS003) which is showing exciting and breakthrough treatment potential even at the current screening stages. Full press release here: https://lnkd.in/ejTwhY73
Pale Blue Dot® Recruitment | The Experts in MedTech Recruitment
4moWell done to all the team OmniSpirant Limited